The development and psychometric validation of the central sensitization inventory

Area of Science:

• Pain Medicine
• Psychometrics
• Rheumatology

Background:

• Central sensitization (CS) is a proposed mechanism for syndromes lacking clear organic causes.
• Central Sensitivity Syndromes (CSS) encompass poorly understood disorders linked to CS.
• A validated instrument is needed to quantify CS symptoms and differentiate CSS.

Purpose of the Study:

• To develop the Central Sensitization Inventory (CSI) for identifying and quantifying CSS symptoms.
• To evaluate the CSI's utility in differentiating chronic pain patients based on CS impairment.
• To assess the CSI's psychometric properties and construct validity.

Main Methods:

• Study 1: Developed and assessed the CSI's psychometric properties (reliability, Cronbach's alpha) in normative subjects.
• Factor analysis of normative and chronic pain subjects identified key symptom clusters.
• Study 2: Administered the CSI to fibromyalgia, chronic widespread pain, chronic low back pain, and normative control groups.

Main Results:

• The CSI demonstrated strong psychometric properties (test-retest reliability = 0.817; Cronbach's alpha = 0.879).
• Factor analysis revealed 4 major symptom factors accounting for 53.4% of the variance.
• Fibromyalgia patients reported significantly higher CSI scores than other groups, including controls.
• Prevalence of diagnosed CSSs was highest in fibromyalgia patients and lowest in controls (P < 0.001).

Conclusions:

• The Central Sensitization Inventory (CSI) is a psychometrically sound and clinically useful tool.
• The CSI demonstrates construct validity in evaluating CS-related symptoms in chronic pain populations.
• The CSI can differentiate between patient groups with varying degrees of central sensitization impairment.